Related Experiment Video
Updated: Sep 25, 2026

Live Imaging and Quantification of Viral Infection in K18 hACE2 Transgenic Mice Using Reporter-Expressing Recombinant SARS-CoV-2
Published on: November 5, 2021
COVID-19 in China: From epidemiology to treatment (Review)
Hongtao Chen1,2, Shipin Wu1, Xiaoyong Zhang3
1Department of Infectious Diseases, The Second Clinical Medical College, Shenzhen People's Hospital, Jinan University, Shenzhen, Guangdong 518020, P.R. China.
Insights
This review covers Coronavirus disease 2019 (COVID-19), a novel infectious disease caused by SARS-CoV-2. It details the prevalence, etiology, pathology, clinical signs, diagnosis, and treatment of COVID-19 in China.
Area of Science:
- Infectious Diseases
- Public Health
- Virology
Background:
- Coronavirus disease 2019 (COVID-19) emerged in Wuhan, China, in December 2019.
- Caused by the novel SARS-CoV-2, it rapidly spread globally.
- Initial symptoms included pneumonia, fever, cough, and fatigue.
Purpose of the Study:
- To review the prevalence of COVID-19 in China.
- To outline the etiology, pathology, and clinical presentation of the disease.
- To discuss diagnostic methods and treatment strategies for COVID-19.
Main Methods:
- Literature review of COVID-19 cases and research.
- Analysis of epidemiological data from China.
- Synthesis of information on clinical characteristics and diagnostic findings.
Main Results:
- As of March 9, 2020, China reported 80,924 confirmed cases and 3,140 deaths.
- The review details the infectious nature and rapid transmission of SARS-CoV-2.
- Key clinical features, laboratory findings, and imaging results are presented.
Conclusions:
- COVID-19 represents a significant global health challenge.
- Understanding the disease's characteristics is crucial for effective management.
- This review provides a comprehensive overview of early findings on COVID-19 in China.
Abstract:
Coronavirus disease 2019 (COVID-19) is a newly emerging infectious disease caused by the novel coronavirus SARS-CoV-2. It first became prevalent in Wuhan, Hubei, China in December 2019. COVID-19 was initially characterized by pneumonia of unknown etiology, accompanied by fever, dry cough and fatigue. Due to its highly infectious nature it rapidly led to widespread human infection, causing 80,924 confirmed cases and 3,140 mortalities in mainland China as of March 9, 2020. The present review highlights the prevalence of COVID-19 in China, the etiology, pathology, clinical presentation, laboratory and chest imaging tests, and treatment of this disease.
More Related Videos
Related Concept Videos
Single Nucleotide Polymorphisms-SNPs
Cancer Therapies
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Pneumonia IV: Management
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
Coronavirus

